NCAM1 and B-cell chronic lymphocytic leukemia: There was a great variability between the levels of NK cells (CD3-CD56+) between the cohorts and pre- and post-vaccination samples, being the individuals with CLL those with more reduced levels before vaccination (Figure 5C, left graph).